| 2005 |
WNT7B activates canonical (β-catenin) Wnt signaling by binding to Frizzled-1 (Fzd1) and Frizzled-10 (Fzd10) on the cell surface, and cooperatively activates canonical Wnt signaling with these receptors in the presence of LRP5 co-receptor; it does not activate the noncanonical Wnt pathway in these cell types. |
Cell transfection assays, biochemical cell-surface binding studies, canonical vs. non-canonical Wnt pathway reporter assays |
Molecular and Cellular Biology |
High |
15923619
|
| 2005 |
Macrophage-derived WNT7B acts as a short-range paracrine signal that activates the canonical WNT pathway in vascular endothelial cells of hyaloid vessels, triggering programmed cell death (apoptosis) and vessel regression during eye development. |
Conditional genetic deletion of Wnt7b in macrophages in mice, analysis of canonical WNT pathway responses and apoptosis in hyaloid vessel endothelial cells |
Nature |
High |
16163358
|
| 2010 |
Macrophage-derived WNT7B stimulates canonical Wnt pathway responses in kidney epithelial cells to promote tissue repair and regeneration after injury; inducible ablation of macrophages reduces canonical Wnt pathway activity in kidney epithelium, and somatic deletion of Wnt7b in macrophages greatly diminishes kidney repair. |
Inducible macrophage ablation, conditional somatic deletion of Wnt7b in macrophages, canonical Wnt pathway reporter analysis in kidney epithelial cells |
Proceedings of the National Academy of Sciences of the United States of America |
High |
20160075
|
| 2002 |
Wnt7b expressed in airway epithelium is required for mesenchymal proliferation and vascular smooth muscle development in the lung; germline deletion causes lung hypoplasia and defects in smooth muscle of major pulmonary vessels leading to hemorrhage. |
Germline knockout mouse (replacement of first exon with lacZ), histological and phenotypic analysis |
Development (Cambridge, England) |
High |
12361974
|
| 2009 |
Wnt7b expressed in collecting duct epithelium regulates the orientation of epithelial cell division planes (longitudinal vs. radial axis) via paracrine canonical Wnt signaling through β-catenin in the underlying interstitium, thereby establishing the cortico-medullary axis and enabling urine concentration; removal of β-catenin from Wnt-responsive interstitium phenocopies the Wnt7b mutant medullary defect. |
Conditional Wnt7b knockout, β-catenin conditional knockout in interstitium, analysis of cell division plane orientation, urine concentration assays, genetic epistasis |
Development (Cambridge, England) |
High |
19060336
|
| 2008 |
Conditional Wnt7b-null lungs are hypoplastic due to decreased replication of both epithelium and mesenchyme; Wnt7b activates both autocrine and paracrine canonical Wnt signaling cascades and modulates multiple downstream signaling pathways to coordinate proliferation of adjacent cell types. |
Conditional Wnt7b knockout mouse, BrdU/proliferation assays, canonical Wnt pathway analysis in epithelium and mesenchyme |
Development (Cambridge, England) |
High |
18367557
|
| 2001 |
Wnt7b expression in the chorion is required for chorion-allantois fusion during placental development; in Wnt7b mutant mice, α4 integrin protein (required for chorioallantoic fusion) is not expressed by cells in the mutant chorion. |
Targeted germline mutation of mouse Wnt7b, immunohistochemistry for α4 integrin, histological analysis |
Developmental Biology |
High |
11543617
|
| 2002 |
WNT7B promoter is directly regulated by the lung-restricted transcription factors TTF-1, GATA6, and Foxa2; TTF-1 and GATA6 physically interact in vivo and synergistically activate the WNT7B promoter, and GATA6/Foxa2 binding site truncations reduce trans-activation. |
Electrophoretic mobility shift assays (EMSA), cotransfection reporter assays, promoter truncation analysis, co-immunoprecipitation (TTF-1/GATA6 interaction) |
The Journal of Biological Chemistry |
High |
11914369
|
| 2014 |
WNT7B promotes bone formation by activating mTORC1 through the PI3K-AKT signaling pathway; genetic disruption of mTORC1 (by deleting Raptor in the osteoblast lineage) alleviates the WNT7B-induced high-bone-mass phenotype, establishing mTORC1 as a required downstream effector. |
Conditional transgenic overexpression of WNT7B in osteoblasts, conditional knockout of Raptor in osteoblasts, bone mass analysis, pathway activity assays |
PLoS Genetics |
High |
24497849
|
| 2017 |
Reck (GPI-anchored membrane protein) and Gpr124 (orphan GPCR) function as essential receptor cofactors for WNT7A/WNT7B-specific signaling in CNS vascular endothelial cells; the most N-terminal domain of Reck binds to the LRR and Ig domains of Gpr124; soluble Gpr124(LRR-Ig) probe binds to cells expressing Frizzled, WNT7A or WNT7B, and Reck; soluble Reck(CC1-5) probe binds to cells expressing Frizzled, WNT7A or WNT7B, and Gpr124, indicating a multiprotein complex. |
EC-specific conditional knockouts of Reck, targeted mutagenesis of Reck-Gpr124 interface, soluble probe binding assays, CNS angiogenesis and BBB phenotype analysis |
Neuron |
High |
28803732
|
| 2014 |
Myeloid cell-derived WNT7B mediates the angiogenic switch in breast cancer by activating Wnt/β-catenin signaling specifically in vascular endothelial cells (VECs), increasing VEGFA mRNA and protein expression in VECs; myeloid-specific Wnt7b deletion reduces VEC Wnt/β-catenin target gene expression, reduces tumor-associated VEGFA, impairs angiogenesis, and diminishes macrophage-mediated tumor cell invasion and lung metastasis. |
Myeloid-specific conditional Wnt7b knockout in MMTV-PymT breast cancer model, Wnt/β-catenin pathway reporter analysis in VECs, VEGFA expression analysis, tumor angiogenesis and metastasis assays |
Cancer Research |
High |
24638982
|
| 2018 |
Wnt7b signals through the Frizzled-7 (Fz7) receptor in hippocampal neurons to promote dendritic arborization via a non-canonical Wnt pathway; Fz7 loss-of-function impairs dendritic growth both in vitro and in vivo in the mouse hippocampus; Wnt7b-Fz7 signaling induces phosphorylation of CaMKII and JNK, both required for dendritic development. |
Fz7 loss-of-function (shRNA and dominant-negative), in vivo dendritic analysis in mouse hippocampus, Western blot for CaMKII and JNK phosphorylation, pharmacological inhibition |
Journal of Cell Science |
High |
29898920
|
| 2013 |
WNT7B drives autocrine Wnt/β-catenin signaling in pancreatic adenocarcinoma (PDAC) cells; WNT7B knockdown reduces Wnt/β-catenin transcriptional activity and anchorage-independent growth, and WLS silencing or IWP-2 (which blocks Wnt ligand processing/secretion) also inhibits Wnt/β-catenin activity, placing WNT7B upstream as the primary ligand. |
siRNA knockdown of WNT7B in PDAC cell lines, WLS silencing, IWP-2 treatment, Wnt/β-catenin luciferase reporter assay, anchorage-independent growth assay |
Oncogene |
High |
23416978
|
| 2013 |
WNT7B is a direct androgen receptor (AR) target gene in castration-resistant prostate cancer (CRPC); WNT7B promotes androgen-independent growth of CRPC cells through activation of protein kinase C (PKC) isozymes (non-canonical Wnt pathway); WNT7B produced by prostate cancer cells induces osteoblast differentiation through direct cell-cell interaction. |
AR chromatin immunoprecipitation, WNT7B knockdown in CRPC cells, PKC pathway inhibitors, osteoblast co-culture differentiation assays |
Molecular Cancer Research |
Medium |
23386686
|
| 2013 |
Dkk1 (a Wnt antagonist) inhibits Wnt7b-induced canonical Wnt signaling in kidney collecting duct cells; Dkk1 deficiency in the developing kidney leads to increased expression of canonical Wnt target Lef-1 in stromal cells, and Dkk1 regulates the degree of Wnt7b signaling during kidney papilla development. |
Recombinant Dkk1 protein treatment of cultured cells with Wnt7b stimulation, conditional Dkk1 knockout mouse, Lef-1 expression analysis |
Developmental Biology |
Medium |
21354128
|
| 2013 |
In aortic endothelial cells, Wnt7b and Msx2 preserve endothelial cell phenotype and maintain expression of EC differentiation markers; endothelial cell-specific deletion of Wnt7b (using Cdh5-Cre) in Wnt7b(fl/fl);LDLR(-/-) mice upregulates aortic osteogenic genes (Osx, Sox9, Runx2, Msx2) and activates Smad1/5 phosphorylation, indicating that EC Wnt7b suppresses endothelial-mesenchymal transition. |
Endothelial-specific conditional Wnt7b knockout (Cdh5-Cre), adenoviral Dkk1/Wnt7b/Msx2 overexpression in primary aortic ECs, Western blot, gene expression analysis |
Arteriosclerosis, Thrombosis, and Vascular Biology |
High |
23685555
|
| 2019 |
Wnt7b promotes bone formation through stimulation of glucose metabolism (glycolysis) in osteoblast lineage cells; Wnt7b increases GLUT1 expression and glucose consumption, and genetic deletion of GLUT1 (Glut1) essentially abolishes Wnt7b-induced bone formation in vivo, demonstrating GLUT1-dependent glycolysis as a required downstream mechanism. |
Compound transgenic mice overexpressing Wnt7b with conditional Glut1 deletion, in vivo bone formation assays (μCT), primary osteoblast culture differentiation, glucose consumption assays |
FASEB Journal |
High |
30913395
|
| 2018 |
Wnt7b acts through Frizzled-7 (Fz7) and the scaffold protein Dvl1 to modulate dendrite arborisation via non-canonical Wnt signaling in hippocampal neurons (β-catenin-independent pathway). |
Loss-of-function (Fz7 knockdown), in vitro and in vivo dendritic arborization analysis, reference to Dvl1 scaffold role |
Journal of Cell Science |
Medium |
29898920
|
| 2008 |
Wnt7b is a p53 transcriptional target gene in PC12 neuronal cells; NGF signaling stabilizes p53, which induces wnt7b expression in a p53-dependent manner; secreted Wnt7b promotes neurite outgrowth through non-canonical JNK signaling (not β-catenin nuclear translocation); sFRP1 inhibits wnt7b-dependent JNK phosphorylation, confirming that Wnt7b is secreted and acts extracellularly. |
Stable shRNA-mediated p53 silencing, wnt7b overexpression rescue of neurite outgrowth in p53-silenced cells, JNK inhibitor (SP600125), sFRP1 treatment, β-catenin nuclear localization assay |
Differentiation |
Medium |
18177422
|
| 2014 |
In hair follicle stem cells (hfSCs), Wnt7b is a direct transcriptional target of canonical BMP signaling; conditional Wnt7b gene targeting disrupts hair follicle cycling (shorter anagen, premature catagen), diminishes HF differentiation markers, and delays HF activation, demonstrating a non-redundant role for Wnt7b in anagen length and catagen entry. |
Conditional Wnt7b knockout (morphogenesis and postnatal), BMP signaling manipulation, flow cytometry, BrdU labeling, marker expression analysis |
Stem Cells |
High |
24222445
|
| 2021 |
The lncRNA Lnc-Rewind acts as an epigenetic regulator that represses Wnt7b expression in muscle stem cells (MuSCs) in cis; Lnc-Rewind interacts with the G9a histone lysine methyltransferase and mediates repression of Wnt7b by H3K9me2 deposition at the Wnt7b locus. |
RNA immunoprecipitation (RIP) for G9a interaction, ChIP for H3K9me2 at Wnt7b locus, lncRNA loss-of-function, RNA-seq in MuSCs |
eLife |
Medium |
33432928
|
| 2018 |
The histone demethylase LSD1 (KDM1A) epigenetically represses WNT7B expression in osteoblasts; LSD1 deficiency results in increased WNT7B expression, enhanced osteoblast differentiation, and increased bone mass; genetic downregulation of WNT7B-related signaling attenuates the bone phenotype in LSD1-deficient mice. |
LSD1 knockdown in human MSCs, conditional LSD1 knockout mice, WNT7B expression analysis, genetic inhibition of WNT7B signaling, small-molecule inhibitor studies |
Bone Research |
Medium |
29707403
|
| 2016 |
Wnt7b expressed in ureteric bud epithelium activates canonical Wnt signaling in mural cells of periureteric bud capillaries in the renal medulla; Wnt7b loss enhances proliferation of target mural cells (associated with decreased PDGFRβ and p57kip2 expression) and impairs capillary lumen formation by reducing VE-cadherin at the cell surface of medullary capillary endothelium. |
Conditional Wnt7b knockout, immunofluorescence for mural cell markers, VE-cadherin localization analysis, proliferation assays |
Journal of the American Society of Nephrology |
Medium |
27432740
|
| 2022 |
EZH2 interacts with HP1BP3 in glioma stem cells, impairing H3K9 methylation, and this EZH2-HP1BP3 complex co-activates WNT7B expression; autocrine WNT7B/β-catenin signaling promotes TMZ resistance and stemness in GBM, and WNT7B inhibition (LGK974) reverses TMZ resistance. |
Co-immunoprecipitation plus mass spectrometry, ChIP, WNT7B overexpression/knockdown, LGK974 WNT secretion inhibitor, TMZ resistance assays, glioma stem cell self-renewal assays |
Oncogene |
Medium |
36517590
|
| 2020 |
Wnt7b-induced Sox11 expression in bone marrow mesenchymal stem cells (BMSCs) enhances self-renewal and osteogenic differentiation; this signaling is β-catenin-independent and instead activates Ca2+-dependent Nfatc1 signaling to directly induce Sox11 transcription; Sox11 in turn activates transcription of proliferation-related (Ccnb1, Sox2) and osteogenesis-related (Runx2, Sp7) factors. |
Transgenic mouse overexpression, RNA-seq, ChIP-qPCR (Sox11 binding to target promoters), shRNA knockdown, colony formation and osteogenic differentiation assays, Nfatc1 pathway analysis |
Stem Cells |
Medium |
32346881
|
| 2017 |
WNT7B promotes migration and differentiation (odontogenic/osteogenic) of human dental pulp cells partly through activation of both the canonical WNT/β-catenin pathway and the non-canonical JNK pathway; pharmacological inhibition of either pathway (XAV939 or SP600125) partly offsets WNT7B-induced differentiation. |
Recombinant WNT7B protein treatment, WNT/β-catenin luciferase reporter, Western blot for pathway activation, pathway inhibitors (XAV939, SP600125), ALP activity, alizarin red staining, scratch assay |
Archives of Oral Biology |
Medium |
29268145
|
| 2024 |
Wnt7b acts as a non-canonical Wnt (ncWnt) ligand in concert with Wnt5a to regulate cochlear duct elongation and planar cell polarity; Wnt5a/Wnt7b are redundantly required for cochlear morphogenesis; mechanistically, Wnt5a/Wnt7b-mediated ncWnt signaling promotes membrane recruitment of Daple (a Gαi guanine nucleotide exchange factor) and activates PI3K/AKT and ERK signaling to regulate asymmetric Fzd6 localization. |
Conditional/conventional loss-of-function mouse genetics (Wnt5a/Wnt7b double KO), PI3K/AKT and ERK pathway analysis, PCP protein localization (Fzd6, Dvl2), Daple membrane recruitment assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
39172791
|
| 2022 |
The WNT7A/WNT7B-FRIZZLED-LRP5/LRP6-GPR124-RECK signaling system functions as an integral unit in limb development; loss-of-function alleles for Wnt7a, Wnt7b, Gpr124, and Reck synergize to cause reduced and dysmorphic limb bone growth, and a Reck allele specifically defective in WNT7A/WNT7B signaling recapitulates limb phenotypes. |
Combinations of conventional and conditional loss-of-function alleles for Wnt7a, Wnt7b, Gpr124, Reck in mice; Reck structure-function allele specifically defective in WNT7A/WNT7B signaling; limb bone growth and patterning analysis |
Development (Cambridge, England) |
High |
35552394
|
| 2021 |
WNT7B/FZD5 signaling activates a pathway involving ELF3 transcription factor, which in turn transcriptionally modulates NOTCH1, functioning as a tumor-suppressing axis in bladder urothelial carcinoma that represses EMT, stem-like properties, and chemoresistance. |
Loss-of-function and gain-of-function studies in bladder cancer cell lines, receptor identification (FZD5 as WNT7B receptor), downstream ELF3/NOTCH1 pathway analysis, EMT and stemness marker assays |
Biochimica et Biophysica Acta – Molecular Basis of Disease |
Medium |
34562599
|
| 2015 |
In human pancreatic progenitor cells (PPCs), WNT7B (and Wnt7a) specifically promotes progenitor cell proliferation through the non-canonical Wnt/PKC pathway, not the canonical Wnt pathway; YY1 functions as a transcriptional regulator of WNT7B expression in PPCs. |
siRNA screening, feeder cell lines stably expressing individual Wnt ligands, canonical vs. non-canonical Wnt pathway reporters, phosphoproteome analysis, YY1 transcriptional regulator identification |
Cell Chemical Biology |
Medium |
33125912
|
| 2019 |
Wnt7b promotes dentinogenesis by increasing proliferation and differentiation of dental mesenchymal cells partly through the ERK1/2 pathway; transgenic mice overexpressing Wnt7b in odontoblasts show increased p-ERK1/2, thinner predentin, and thicker intertubular dentin with higher mineral content; ERK1/2 inhibition partly rescues Wnt7b-induced differentiation. |
Dmp1-cre;ROSA26-Wnt7b transgenic mice, adenoviral Wnt7b overexpression in dental papillae cells, ERK1/2 inhibitor, Western blot, micro-CT, ALP/alizarin red staining |
Archives of Oral Biology |
Medium |
31181411
|
| 2022 |
Bi-allelic loss-of-function variants in WNT7B cause PDAC syndrome (pulmonary hypoplasia, diaphragmatic anomalies, anophthalmia/microphthalmia, cardiac defects); functional validation using a canonical WNT signaling luciferase assay demonstrated that identified WNT7B variants (p.Arg98*, p.Tyr75*, p.Gly188Ser) are deleterious to WNT7B signaling activity. |
Whole-exome sequencing, canonical WNT signaling luciferase reporter assay for variant functional validation, wnt7bb mutant zebrafish (swimbladder phenotype) |
Journal of Medical Genetics |
Medium |
35790350
|
| 2023 |
Wnt7b expressed by hypertrophic chondrocytes promotes endochondral ossification; Wnt7b expression in growth plate cartilage is suppressed by BMP4/Smad4 signaling; ablation of Wnt7b in Smad4 cKO mice blunts the increased bone volume phenotype, establishing Wnt7b-β-catenin as a downstream effector of Smad4-BMP signaling during endochondral ossification. |
Conditional Smad4 knockout, conditional Wnt7b knockout in Smad4 cKO background (genetic epistasis), BMP4 stimulation in chondrocytes, bone volume analysis |
Development (Cambridge, England) |
Medium |
37539462
|
| 2024 |
WNT7B binds to FZD4 (frizzled-4) receptor in periodontal ligament stem cells; Wnt7b overexpression promotes osteogenic differentiation and suppresses M1 macrophage polarization; FZD4 silencing reverses these effects, placing FZD4 as the receptor mediating WNT7B function in this context. |
Co-immunoprecipitation (WNT7B-FZD4 binding), FZD4 siRNA rescue experiments, osteogenic differentiation assays, macrophage polarization assays, Western blot |
Molecular Medicine Reports |
Medium |
39301638
|
| 2021 |
WNT7B in cholangiocytes induces a proproliferative, proinflammatory program: in vitro, Wnt7b induces cholangiocyte proliferation and secretion of proinflammatory cytokines in an autocrine manner; loss of cholangiocyte/hepatocyte Wnt7b in vivo improves biliary injury and decreases cellular senescence in cholestasis, and Wnt7b suppression promotes hepatocyte reprogramming toward a biliary phenotype. |
Conditional Wnt7b knockout (Krt19-Cre and Albumin-Cre), DDC cholestasis model, proliferation assays, cytokine secretion assays, senescence markers, hepatocyte reprogramming markers |
Hepatology Communications |
Medium |
34558852
|
| 2018 |
In the context of partially impaired Norrin signaling, the Wnt7a/Wnt7b system makes a contribution to blood-retina barrier (BRB) development; combined loss of Wnt7a and Norrin or Wnt7a and Frizzled4 causes far more severe BBB defects than loss of any single component, demonstrating partial redundancy between the Wnt7a/Wnt7b and Norrin signaling systems in BBB/BRB maintenance. |
Compound conditional knockouts (Wnt7a, Wnt7b, Norrin, Frizzled4, Tspan12) in mice, BBB/BRB phenotype analysis, glial-specific Wnt7a deletion |
Proceedings of the National Academy of Sciences of the United States of America |
High |
30478038
|
| 2024 |
A founder WNT7B variant (Arg247Trp) significantly impairs WNT7B canonical signaling activity as demonstrated by luciferase reporter assay, causing variable PDAC syndrome phenotypes including isolated genitourinary anomalies, expanding the known phenotypic spectrum. |
Canonical WNT signaling luciferase reporter assay for variant functional validation |
Clinical Genetics |
Low |
38417950
|